ITEM 4. INFORMATION ON THE COMPANY 4.A. History and Development of the Company Capital Pool Company The Company was incorporated by registration of its Memorandum and Articles under the BC Companies Act on May 30, 2000 under the name “Duft Biotech Capital Ltd.” and was classified as a Capital Pool Company (“CPC”) on the TSX Venture Exchange. Under the policies of the TSX Venture Exchange, the principal business of a CPC is to identify and evaluate opportunities for acquisition. The completion of such an acquisition is referred to as a Qualifying Transaction. A CPC does not carry on any business other than the identification and evaluation of assets or businesses in connection with potential Qualifying Transactions, does not have business operations or assets other than seed capital and has no written or oral agreements for the acquisition of an asset or business at the time of formation.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 3.5M | 3.5M | 2.6M | 1.4M | - | - |
| Net Income | -488K | -488K | -519K | -628K | -1.4M | -876K |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.01 | $-0.01 | $-0.01 |
| Free Cash Flow | 600K | 600K | -268K | -1.3M |
| Metric | 2015 | 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | N/A | 1.9M | 0 | N/A | N/A | N/A | N/A | 1.4M | 2.6M | 3.5M | 3.5M |
| Gross Margin | N/A | 12.3% | N/A | N/A | N/A | N/A | N/A | 25.8% | 34.5% | 39.3% | 39.3% |
| R&D | 44K | 158K | 187K | 194K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 584K | 395K | 395K | 291K | 150K | 85K | 146K | 192K | 251K | 298K | 298K |
| EBIT | N/A | 767K | -2.1M | -3.2M | -1.6M | -757K | 98K | -598K | -491K | N/A | 0 |
| Op. Margin | N/A | 41.2% | N/A | N/A | N/A | N/A | N/A | -44.1% | -19.0% | N/A | 0.0% |
| Net Income | -1.7M | -2.0M | -2.1M | -3.2M | -1.6M | -876K | -1.4M | -628K | -519K | -488K | -488K |
| Net Margin | N/A | -106.2% | N/A | N/A | N/A | N/A | N/A | -46.3% | -20.1% | -14.0% | -14.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 135K | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||
| ROIC | N/A | 41.7% | -86.5% | N/M | N/M | -182.3% | N/A | -31.3% | -26.1% | N/A | 0.0% |
| ROE | -67.8% | -101.2% | -123.9% | -244.5% | -1001.4% | N/A | N/A | -39.3% | -35.3% | -33.6% | -34.0% |
| ROA | N/A | N/A | -94.4% | -201.8% | -299.0% | -362.1% | -125.5% | -33.7% | -27.5% | -27.7% | -29.1% |
| Cash Flow | |||||||||||
| Op. Cash Flow | -1.2M | -1.6M | -804K | -1.1M | -519K | -913K | -984K | -336K | 489K | 732K | 732K |
| Free Cash Flow | -1.2M | -1.6M | -804K | -1.1M | -519K | -913K | -1.1M | -1.3M | -268K | 600K | 600K |
| Owner Earnings | -1.2M | -1.6M | -804K | -1.5M | -655K | -913K | -998K | -336K | 487K | 730K | 730K |
| CapEx | 24K | 5K | 0 | 0 | 0 | 0 | 84K | 915K | 757K | 132K | 132K |
| Maint. CapEx | 0 | 0 | 0 | 412K | 136K | 0 | 14K | 0 | 2K | 2K | 2K |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | N/A | 70K | N/A | 755K | 130K | 130K |
| D&A | 0 | 0 | 0 | 412K | 136K | 0 | 14K | 0 | 2K | 2K | 2K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 18.0% |
| Capital Allocation | |||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 26K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||
| Net Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -825K |
| Cash & Equiv. | 1.7M | 324K | 432K | 65K | 10K | 226K | 1.6M | 476K | 205K | 825K | 825K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | N/A | N/A | 0.16 | 0.35 | -1.45 | -1.62 | N/A | 0.31 | 0.26 | 0.17 | 0.00 |
| Interest Coverage | N/A | N/A | -10444.5 | -40555.9 | -408.3 | -6.4 | 3.2 | -20.3 | -17.2 | N/A | N/A |
| Equity | 2.5M | 1.5M | 1.9M | 682K | -352K | -533K | N/A | 1.5M | 1.5M | 1.4M | 1.4M |
| Total Assets | N/A | N/A | 2.2M | 924K | 157K | 328K | 1.8M | 2.0M | 1.9M | 1.7M | 1.7M |
| Total Liabilities | N/A | N/A | 311K | 242K | 509K | 861K | N/A | 464K | 392K | 241K | 241K |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -12M | -14M | -16M | -19M | -21M | -21M | -24M | -24M | -24M | -24M | -24M |
| Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 211K | 913K | 913K |
| Current Assets | N/A | N/A | 1.3M | 580K | 157K | 328K | 1.7M | 1.1M | 573K | 1.2M | 1.2M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 362K | 241K | 241K |
| Per Share Data | |||||||||||
| EPS | -0.39 | -0.09 | N/A | N/A | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
| Owner EPS | -0.11 | -0.07 | N/A | N/A | -0.00 | -0.01 | -0.01 | -0.00 | 0.00 | 0.01 | 0.01 |
| Book Value | 0.24 | 0.07 | N/A | N/A | -0.00 | -0.00 | N/A | 0.01 | 0.01 | 0.01 | 0.01 |
| Cash Flow/Share | -0.11 | -0.07 | N/A | N/A | -0.00 | -0.01 | -0.01 | -0.00 | 0.00 | 0.01 | -0.00 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 10.5M | 22.0M | N/A | N/A | 147.7M | 150.3M | 129.3M | 123.9M | 106.2M | 101.3M | 101.3M |
| Valuation | |||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.2 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.1 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.1 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0 |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 740.5% |
| Market Cap | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 81K |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Avricore Health Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 33.2%.
Avricore Health Inc. (AVCRF) has a 5-year average return on invested capital (ROIC) of -79.9%. This is below average and may indicate limited pricing power.
Avricore Health Inc. (AVCRF) has a market capitalization of $81K. It is classified as a small-cap stock.
Avricore Health Inc. (AVCRF) does not currently pay a regular dividend.
Avricore Health Inc. (AVCRF) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
Avricore Health Inc. (AVCRF) reported annual revenue of $3 million in its most recent fiscal year, based on SEC EDGAR filings.
Avricore Health Inc. (AVCRF) has a net profit margin of -14.0%. The company is currently unprofitable.
Avricore Health Inc. (AVCRF) generated $600 thousand in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
| -1.1M |
| -913K |
| ROIC | 0.0% | - | -26.1% | -31.3% | - | -182.3% |
|---|
| Gross Margin | 39.3% | 39.3% | 34.5% | 25.8% | - | - |
|---|
| Debt/Equity | 0.00 | 0.17 | 0.26 | 0.31 | - | -1.62 |
|---|
| Dividends/Share | $0.00 | - | - | - | - | - |
|---|
| Operating Income | 0 | - | -491K | -598K | 98K | -757K |
|---|
| Operating Margin | 0.0% | - | -19.0% | -44.1% | - | - |
|---|
| ROE | -34.0% | -33.6% | -35.3% | -39.3% | - | - |
|---|
| Shares Outstanding | 101M | 101M | 106M | 124M | 129M | 150M |
|---|
Avricore Health Inc. (AVCRF) has a debt-to-equity ratio of 0.17. This indicates a conservatively financed balance sheet.
Avricore Health Inc. (AVCRF) reported earnings per share (EPS) of $-0.00 in its most recent fiscal year.
Avricore Health Inc. (AVCRF) has a return on equity (ROE) of -33.6%. A negative ROE may indicate losses or negative equity.
Avricore Health Inc. (AVCRF) has a 5-year average gross margin of 33.2%. This indicates decent pricing power.
The Ledger Terminal provides 10 years of financial data for Avricore Health Inc. (AVCRF), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Avricore Health Inc. (AVCRF) has a book value per share of $0.01, based on its most recent annual SEC filing.
No recent items.